Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Multi-center, Prospective and Retrospective Observational Study to Evaluate the Long-term Safety and Effectiveness of Growth Hormone (Eutropin Inj. / Eutropin Plus Inj.) Treatment With GHD, TS, CRF, SGA, ISS and PWS in Children

NCT01604395 is registered in ClinicalTrials.gov with LG Chem as lead sponsor.

NCT NCT01604395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Multi-center, Prospective and Retrospective Observational Study to Evaluate the Long-term Safety and Effectiveness of Growth Hormone (Eutropin Inj. / Eutropin Plus Inj.) Treatment With GHD, TS, CRF, SGA, ISS and PWS in Children
Lead sponsor
LG Chem
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2012
Completion date
December 31, 2032
Enrollment
6,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal failure, growth hormone deficiency, idiopathic short stature, small for gestational age, turner syndrome